The report highlights Mochida Pharmaceutical Group's commitment to sustainable growth and its focus on creating innovative products, particularly in the fields of cardiovascular medicine, obstetrics and gynecology, psychiatry, and gastroenterology. The company also emphasizes its commitment to ESG (environmental, social and governance) considerations and its contribution to the realization of the SDGs. The report details the company's key business activities, including research and development, production, quality control and safety management, sales and information provision, and its healthcare business.
Issuing Company Mochida Pharmaceutical Co., Ltd.
Report Type Integrated Report
Report Language EN
Report Filesize 6.94 MB
No. of Pages 22 pages
Reporting periodApril 1, 2020-March 31, 2021
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards International Integrated Reporting Framework; IIRC
Materiality Assessmenttrue
